4//SEC Filing
Daniels Karen K. 4
Accession 0001593968-19-002187
CIK 0000887247other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:48 PM ET
Size
5.5 KB
Accession
0001593968-19-002187
Insider Transaction Report
Form 4
Daniels Karen K.
Vice President of Operations
Transactions
- Sale
Common Stock
2019-11-18$0.83/sh−5,421$4,499→ 163,689 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in March 2019.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.86, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001530197
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:48 PM ET
- Size
- 5.5 KB